Provides that Medicaid and policies issued in this state that provide coverage for hospital, surgical or medical care shall provide coverage for standard fertility preservation services when a necessary cancer treatment may directly or indirectly cause iatrogenic infertility to a covered person.
Summary
Bill S03745 amends the insurance law and social services law in New York to require that all health insurance policies and Medicaid coverage provide benefits for standard fertility preservation services when a necessary cancer treatment poses a risk of causing iatrogenic infertility. This includes coverage for individuals undergoing surgery, radiation, chemotherapy, or other treatments that may impair fertility. The bill specifies that such coverage cannot be restricted based on the age of the covered person, ensuring equitable access to these services for all individuals affected by cancer treatment.
Impact
The passage of this bill would significantly enhance the rights of patients undergoing cancer treatment in New York by mandating insurance coverage for fertility preservation services. This change would directly affect health insurance providers and Medicaid programs, requiring them to include these services in their coverage plans. It aims to alleviate the financial burden on patients who wish to preserve their fertility before undergoing treatments that may lead to infertility, thereby promoting better health outcomes and family planning options for cancer survivors.
Sentiment
The sentiment surrounding Bill S03745 appears to be generally positive, with support from various stakeholders who recognize the importance of fertility preservation for cancer patients. Discussions indicate a growing awareness of the long-term implications of cancer treatments on fertility, and there is an expressed need for comprehensive coverage to support affected individuals. However, there may be concerns regarding the potential costs to insurance providers and the implications for policy premiums.
Contention
Points of contention may arise from insurance companies regarding the financial implications of mandating coverage for fertility preservation services. Some stakeholders may argue that such mandates could lead to increased premiums or limit coverage options for other medical services. On the other hand, advocates for cancer patients emphasize the necessity of these services and the ethical obligation to support individuals facing infertility due to medical treatments.
Provides that Medicaid and policies issued in this state that provide coverage for hospital, surgical or medical care shall provide coverage for standard fertility preservation services when a necessary cancer treatment may directly or indirectly cause iatrogenic infertility to a covered person.
Insurance; medically necessary expenses for standard fertility preservation services when a medically necessary treatment for cancer, sickle cell disease, or lupus may directly or indirectly cause an impairment of fertility; require coverage
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Infertility treatment and standard fertility preservation services coverage by health plans requirement, MinnesotaCare and medical assistance coverage of infertility treatment and standard fertility preservation services requirement, and appropriation